Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

Share

Chiron Pharmasynth AS

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 23,662 Less Arrow 22,533 Less Arrow 15,551
Financial expenses 1 More Arrow 298 Less Arrow 131
Earnings before taxes -250 More Arrow 5,002 Less Arrow 2,001
Total assets 30,994 More Arrow 32,507 Less Arrow 30,085
Current assets 30,994 More Arrow 32,507 Less Arrow 30,085
Current liabilities 12,706 More Arrow 13,635 Less Arrow 11,502
Equity capital 18,288 More Arrow 18,872 Less Arrow 18,583
- share capital 1,721 More Arrow 1,752 More Arrow 1,876

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 59.0% Less Arrow 58.1% More Arrow 61.8%
Turnover per employee
Profit as a percentage of turnover -1.1% More Arrow 22.2% Less Arrow 12.9%
Return on assets (ROA) -0.8% More Arrow 16.3% Less Arrow 7.1%
Current ratio 243.9% Less Arrow 238.4% More Arrow 261.6%
Return on equity (ROE) -1.4% More Arrow 26.5% Less Arrow 10.8%
Change turnover 1,528 More Arrow 8,013 Less Arrow 5,702
Change turnover % 7% More Arrow 55% More Arrow 58%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.